Biostar Pharmaceuticals, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BSPM research report →
Companybiostarpharmaceuticals.com
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B.
- CEO
- Ronghua Wang
- IPO
- 2008
- Employees
- 200
- HQ
- Xianyang, CN
Price Chart
Valuation
- Market Cap
- $264
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -1.27
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 38.39%
- Op Margin
- -149.50%
- Net Margin
- -239.01%
- ROE
- -14.04%
- ROIC
- -9.09%
Growth & Income
- Revenue
- $2.38M · -91.21%
- Net Income
- $-5,698,000 · 77.31%
- EPS
- $-2.50 · 77.99%
- Op Income
- $-3,564,000
- FCF YoY
- -15.56%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -163.62
- Avg Volume
- 34
Get TickerSpark's AI analysis on BSPM
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 20, 12 | Pan Zibing | other | 24,000 |
| Jun 16, 11 | Wang Ronghua | buy | 13,800 |
| Jun 15, 11 | Wang Ronghua | buy | 14,350 |
| Jun 14, 11 | Wang Ronghua | buy | 35,100 |
| Jun 13, 11 | Wang Ronghua | buy | 22,050 |
| Jun 10, 11 | Wang Ronghua | buy | 19,700 |
| Jun 9, 11 | Wang Ronghua | buy | 12,000 |
| Jun 8, 11 | Wang Ronghua | buy | 34,600 |
| Jun 7, 11 | Wang Ronghua | buy | 8,600 |
| Jun 6, 11 | Wang Ronghua | buy | 10,300 |
Our BSPM Coverage
We haven't published any research on BSPM yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BSPM Report →